Bluejay Diagnostics News

Bluejay Diagnostics Inc Trading Halted, News Pending

TipRanksNov 15 19:50 ET

Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaNov 15 19:50 ET

Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

BenzingaNov 14 05:12 ET

Bluejay Diagnostics, Inc. Announces 1-for-50 Reverse Stock Split Effective November 18, 2024

Quiver QuantitativeNov 13 17:49 ET

Bluejay Diagnostics Announces 1-For-50 Reverse Stock Split, Will Open For Trading On The Nasdaq Capital Market On A Post-Split Basis On November 18, 2024

BenzingaNov 13 17:11 ET

Express News | Bluejay Diagnostics Announces Reverse Stock Split

ReutersNov 13 17:10 ET

Bluejay Diagnostics | 10-Q: Q3 2024 Earnings Report

SECNov 7 16:03 ET · Announcements

Trending Stocks Today | Bluejay Diagnostics Shoots up 111.11%

Moomoo NewsNov 5 13:30 ET

Bluejay Therapeutics Announces Data Presentations in Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at Upcoming American Association for the Study of Liver Diseases (AASLD) The Liver Meeting 2024

BusinesswireOct 16 08:45 ET

12 Health Care Stocks Moving In Monday's After-Market Session

BenzingaSep 2 16:31 ET

Bluejay Diagnostics | 10-Q: Q2 2024 Earnings Report

SECAug 14 16:50 ET · Announcements

Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

BenzingaAug 6 05:16 ET

Express News | Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

ReutersJun 28 11:32 ET

Express News | Bluejay Diagnostics Shares Are Trading Lower After the Company Priced Its Public Offering

BenzingaJun 27 09:09 ET

Express News | Bluejay Diagnostics Priced Underwritten Public Offering Of 5.368M Shares Or Prefunded Warrants, Purchase Price Of Each Common Unit $1.63; Expected Gross Proceeds $8.75M

BenzingaJun 27 09:08 ET

Express News | Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering

ReutersJun 27 08:58 ET

US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data

MT NewswiresJun 27 08:12 ET

Express News | Bluejay Diagnostics Shares Are Trading Lower After the Company Announced SYMON-I Study Results. The Stock Initially Traded Higher, but It Has Since Reverse

BenzingaJun 26 11:34 ET

Bluejay Diagnostics Sees Positive Trial Results for Interleukin-6

WSJJun 26 08:19 ET

Bluejay Diagnostics Announces SYMON-I Study Results; IL-6 Levels Within 24 Hours of ICU Admission Predict 28-Day Mortality in Sepsis and Septic Shock Patients; Findings to Be Validated in SYMON-II Study

BenzingaJun 26 08:02 ET